申请人:Eli Lilly and Company
公开号:US05905084A1
公开(公告)日:1999-05-18
This invention provides 5-HT.sub.1F agonists of Formula: ##STR1## where A-B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing the compounds or the invention as well as methods of treating conditions associated with 5-HT.sub.1F activation employing these compounds or compositions.
本发明提供了公式如下的5-HT.sub.1F激动剂:##STR1## 其中A-B、X和R如规范中定义。本发明还包括使用该化合物或该发明的制剂的制药组合物,以及使用这些化合物或组合物治疗与5-HT.sub.1F激活相关的疾病的方法。